WaveMan · Form 4
Gordon Carl L insider trades
> Search tickers & screens ⌘K
LIVE

Gordon Carl L insider trades

Gordon Carl L has filed 60 Form 4s with the SEC that we hold, for Compass Therapeutics, Inc. (CMPX) (Director), THRX (Director, 10% owner), Adicet Bio, Inc. (ACET) (Director, 10% owner) and KNTE (Director, 10% owner), among 15 companies in all. Across all of them we count 62 purchases worth $142.9M and 10 sales worth $17.3M reported on Form 4. In the last 12 months: 7 purchases ($61.1M) and 0 sales ($0). The largest single trade was a purchase of 1,000,000 shares of Electra Therapeutics, Inc. worth $15.0M, dated 2026-09-21. The first filing on our record is dated 2021-10-06 and the latest 2026-09-30.

Compass Therapeutics, Inc. (CMPX)

Director · 10 filings · 10 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-11-04P, purchase reported on Form 41,785,715$6.3M2021-11-08
2021-11-04P, purchase reported on Form 43,571,428$12.5M2021-11-08
2022-05-06P, purchase reported on Form 410,200$16.6K2022-05-10
2022-05-09P, purchase reported on Form 490,712$141.5K2022-05-10
2022-05-10P, purchase reported on Form 424,447$39.1K2022-05-10
2022-05-11P, purchase reported on Form 464,700$115.8K2022-05-13
2022-05-12P, purchase reported on Form 497,094$228.2K2022-05-13
2022-05-13P, purchase reported on Form 430,722$76.5K2022-05-13
2022-11-08P, purchase reported on Form 4402,000$1.3M2022-11-10
2025-04-09S, sale reported on Form 43,571,428$5.7M2025-04-11

THRX

Director, 10% owner · 9 filings · 12 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-10-12P, purchase reported on Form 462,500$1.0M2021-10-14
2021-10-12P, purchase reported on Form 4562,500$9.0M2021-10-14
2022-01-11P, purchase reported on Form 41,600$15.7K2022-01-13
2022-01-11P, purchase reported on Form 46,900$73.6K2022-01-13
2022-01-12P, purchase reported on Form 418,897$190.1K2022-01-13
2022-01-13P, purchase reported on Form 417,320$163.3K2022-01-13
2022-01-19P, purchase reported on Form 411,521$114.9K2022-01-21
2022-01-20P, purchase reported on Form 435,000$348.2K2022-01-21
2022-01-21P, purchase reported on Form 4111,896$1.1M2022-01-21
2022-11-07P, purchase reported on Form 4192,000$1.0M2022-11-09
2023-07-17P, purchase reported on Form 4151,450$461.9K2023-07-19
2023-07-17P, purchase reported on Form 4328,482$1.0M2023-07-19

Adicet Bio, Inc. (ACET)

Director, 10% owner · 8 filings · 7 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-06-27P, purchase reported on Form 458,000$121.2K2023-06-29
2023-06-27P, purchase reported on Form 4442,000$923.8K2023-06-29
2023-06-27P, purchase reported on Form 4250,000$522.5K2023-06-29
2023-06-27P, purchase reported on Form 4125,000$261.2K2023-06-29
2024-01-25P, purchase reported on Form 4242,200$581.3K2024-01-26
2024-01-25P, purchase reported on Form 41,041,700$2.5M2024-01-26
2024-01-25P, purchase reported on Form 41,841,100$4.4M2024-01-26

KNTE

Director, 10% owner · 7 filings · 16 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-02-11P, purchase reported on Form 4156,000$1.6M2022-02-15
2022-02-14P, purchase reported on Form 420,700$206.6K2022-02-15
2022-02-14P, purchase reported on Form 410,000$98.9K2022-02-15
2022-02-15P, purchase reported on Form 49,000$89.6K2022-02-15
2023-04-28P, purchase reported on Form 460,997$155.5K2023-05-02
2023-04-28P, purchase reported on Form 4228,754$583.3K2023-05-02
2023-04-28P, purchase reported on Form 460,998$155.5K2023-05-02
2023-05-01P, purchase reported on Form 4467,068$1.2M2023-05-02
2023-05-01P, purchase reported on Form 4124,545$326.3K2023-05-02
2023-05-01P, purchase reported on Form 4124,544$326.3K2023-05-02
2023-05-02P, purchase reported on Form 458,826$157.1K2023-05-02
2023-05-02P, purchase reported on Form 4220,610$589.0K2023-05-02
2023-05-04P, purchase reported on Form 4312,991$860.7K2023-05-08
2023-05-04P, purchase reported on Form 483,459$229.5K2023-05-08
2023-05-05P, purchase reported on Form 4490,512$1.4M2023-05-08
2023-05-05P, purchase reported on Form 4490,511$1.4M2023-05-08

TERN

Director, 10% owner · 7 filings · 10 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-08-16P, purchase reported on Form 4762,400$1.8M2022-08-18
2022-08-16P, purchase reported on Form 42,470,200$6.0M2022-08-18
2022-08-16P, purchase reported on Form 4457,400$1.1M2022-08-18
2022-12-23P, purchase reported on Form 4137,931$1,000.0K2022-12-28
2024-07-15S, sale reported on Form 439,433$394.3K2024-07-17
2024-07-15S, sale reported on Form 45,401$54.0K2024-07-17
2024-07-15S, sale reported on Form 46,142$61.4K2024-07-17
2024-07-16S, sale reported on Form 44,009$40.1K2024-07-17
2024-07-16S, sale reported on Form 4623$6.2K2024-07-17
2024-07-16S, sale reported on Form 4556$5.6K2024-07-17

Keros Therapeutics, Inc. (KROS)

Director · 6 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-08-13S, sale reported on Form 4220,600$9.7M2024-08-15
2024-08-13S, sale reported on Form 429,400$1.3M2024-08-15

MBX Biosciences, Inc. (MBX)

Director, 10% owner · 3 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-09-16P, purchase reported on Form 4500,000$8.0M2024-09-17
2024-09-16P, purchase reported on Form 4250,000$4.0M2024-09-17
2025-02-14P, purchase reported on Form 429,540$291.0K2025-02-19
2025-02-14P, purchase reported on Form 417,962$177.8K2025-02-19
2025-02-18P, purchase reported on Form 449,070$531.9K2025-02-19
2025-02-18P, purchase reported on Form 494,100$1.0M2025-02-19

BlossomHill Therapeutics, Inc. (BLSM)

Director · 2 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2026-08-10P, purchase reported on Form 4625,000$10.0M2026-08-12

Scribe Therapeutics, Inc. (SCTX)

Director · 2 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2026-07-27P, purchase reported on Form 41,000,000$15.0M2026-07-29

ADARx Pharmaceuticals, Inc. (ADRX)

Director, 10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-09-28P, purchase reported on Form 4300,249$5.1M2026-09-30
2026-09-28P, purchase reported on Form 461,516$1.0M2026-09-30
2026-09-28P, purchase reported on Form 4588,235$10.0M2026-09-30

ArriVent BioPharma, Inc. (AVBP)

Director, 10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2024-01-30P, purchase reported on Form 4222,222$4.0M2024-01-31

CIK 1900520

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Disc Medicine, Inc. (GMTX)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Electra Therapeutics, Inc. (ETRA)

Director, 10% owner · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-09-21P, purchase reported on Form 4333,333$5.0M2026-09-23
2026-09-21P, purchase reported on Form 41,000,000$15.0M2026-09-23

Tessera Defense & Homeland Security Inc. (PHGE)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2024-05-15S, sale reported on Form 424,344$9.3K2024-05-20
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1282930) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms